AMLN Amylin Pharmaceuticals, Inc. (MM)

Amylin Pharmaceuticals to Present at Goldman Sachs Global Healthcare Conference SAN DIEGO, June 3 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) will be presenting at the Goldman Sachs Global Healthcare Conference on Tuesday, June 8, 2004 at 4:40 p.m. Pacific Time at The Ritz-Carlton in Dana Point, California. Mark G. Foletta, Vice President, Finance and Chief Financial Officer of Amylin Pharmaceuticals, will be providing a corporate overview. The live presentation and breakout session will both be webcast, and recordings will be made available following the events. The webcasts and recordings will be accessible through Amylin's corporate website, located at http://www.amylin.com/. To access the live webcasts, please log on to Amylin's site approximately fifteen minutes prior to the presentation to register and download any necessary audio software. Amylin Pharmaceuticals is committed to improving the lives of people with diabetes and other metabolic diseases through the discovery, development and commercialization of innovative, cost-effective medicines. DATASOURCE: Amylin Pharmaceuticals, Inc. CONTACT: Mark G. Foletta, Vice President of Finance and Chief Financial Officer of Amylin Pharmaceuticals, Inc., +1-858-552-2200 Web site: http://www.amylin.com/

Copyright